.
MergerLinks Header Logo

Announced

Completed

Ardian completed the acquisition of a minority stake in H2 Pharma.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Minority

Friendly

Private

Domestic

Private Equity

France

Acquisition

Pharmaceuticals

Completed

generic drugmaker

Single Bidder

Synopsis

Edit

Ardian, a private investment house, completed the acquisition of a minority stake in H2 Pharma, a manufacturer and distributor of generic pharmaceuticals. Financial terms were not disclosed. "The resilience and engagement of H2 Pharma’s management team have steered the company exceptionally well over the past years and we are looking forward to helping them achieve their vision for this next stage of development. Undoubtedly, the company’s competitiveness also comes from its cutting-edge technology, which places it head and shoulders above many of its peers. We see significant potential for strong organic growth and we look forward to helping management realize this by working closely with Henry and his teams," Frédéric Quéru, Ardian Director.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US